SEC accuses Merck exec of insider trading

In a civil suit filed in Philadelphia, the SEC accused James Self, 45, an executive director at Merck, of feeding his business school buddy and former hedge fund manager Stephen Goldfield, 46, the details of a 2007 Merck deal to buy drug firm MedImmune. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.